Peter Ludlum

Interim CEO, Interim CFO at Pulmatrix.

Earliest Form D on file: Apr 2026

Filed Apr 15, 2026

Pulmatrix

Inhaled dry powder drugs for migraine and lung disease

Biotech, Framingham MA

Signed as Interim CEO, Interim CFO

$1M

sold of $1M offered

Network

At Pulmatrix

5 people